Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",kidney integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000940,percentage of study population developing unilateral renal agenesis during a period of time,,,,0,%,,,MMO:0000344,necropsy,,0.0,,,,,control condition,106884,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",hypodermis integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0003387,percentage of study population developing subcutaneous tumors during a period of time,,CMO:0003387 percentage of study population developing subcutaneous tumors during a period of time,,38,%,,,MMO:0000344,necropsy,,0.0,,,,,control condition,106886,control condition